MEDICINAL CANNABIS DISPENSARY COMPLIANCE
Keep your medicinal cannabis dispensary compliant
HCPA helps pharmacies strengthen medicinal cannabis policies and procedures, dispensing workflows, Schedule 8 controls and audit readiness.
Medicinal cannabis compliance sits alongside the pharmacy's existing professional and premises obligations.
When urgent medicinal cannabis compliance support may help
Regulatory issues are often easier to resolve when the pharmacy responds quickly, preserves evidence and addresses the underlying system.
Advertising concerns
A website, social post, signage or business name may raise concerns if it directly or indirectly promotes medicinal cannabis. The TGA provides guidance on advertising prescription medicines to the public.
Schedule 8 inspection issues
A pharmacy may need support where safe capacity, access controls, refrigeration or other parts of its Schedule 8 storage and handling systems do not meet the relevant state or territory requirements.
Controlled-drug record discrepancies
Differences between physical Schedule 8 stock and the pharmacy’s drug records can raise questions about stock handling, dispensing processes, record accuracy and whether appropriate diversion controls are in place.
Prescriber relationship concerns
A regulator may question whether commercial arrangements with a prescriber, clinic or supplier are influencing professional independence, dispensing decisions or the patient’s freedom to choose their pharmacy.
Key medicinal cannabis dispensary compliance requirements
Medicinal cannabis dispensary compliance needs to cover controlled-drug handling, lawful dispensing, clear operating procedures and how the service is promoted to the public.
Schedule 8 storage and records
THC-containing Schedule 8 medicines must be stored, accessed and recorded in line with the medicines and poisons requirements that apply in the pharmacy’s state or territory. Stock records should also be kept accurate so discrepancies can be identified and investigated quickly.
Medicinal cannabis dispensing regulations
Most medicinal cannabis products are unapproved therapeutic goods, so pharmacies need to confirm that the appropriate prescription and access pathway applies before supply. The TGA’s medicinal cannabis access pathways explain how these medicines can lawfully be accessed.
Medicinal cannabis policies and procedures
Medicinal cannabis policies and procedures should translate these requirements into clear staff workflows. This can include prescription checks, Schedule 8 handling, stock reconciliation, real-time prescription monitoring, patient counselling, incidents and escalation of discrepancies.
Advertising and professional independence
Medicinal cannabis is subject to strict prescription medicine advertising restrictions, including indirect promotion through websites, social media or imagery. The TGA’s prescription medicine advertising guidance should also be considered alongside arrangements with prescribers or suppliers, which should preserve independent dispensing decisions and patient choice.
HCPA can help bring these requirements together into practical medicinal cannabis dispensary SOPs that staff can follow day to day.
Medicinal cannabis dispensary SOPs and audit readiness
Medicinal cannabis dispensary SOPs should show how controlled-drug and dispensing requirements are applied in practice, not simply repeat regulatory wording.
A practical review may include:
Schedule 8 stock against drug-register records
secure storage and authorised access
applicable real-time prescription monitoring
prescription and access-pathway records
ordering and supply-chain documentation
delivery and cold-chain procedures
advertising and public-facing content
staff training and dispensing processes
conflict-of-interest controls
previous findings and corrective actions.
These systems should be reviewed when medicinal cannabis dispensing regulations change, dispensing volume increases or the pharmacy changes how the service operates.
HCPA can review your SOPs, identify compliance gaps and help prepare the pharmacy for inspection or regulatory review.
Speak with an HCPA medicinal cannabis compliance consultantResponding to medicinal cannabis stock or record discrepancies
Understand the discrepancy
Confirm what the inspector or audit has identified, which stock or records are affected and the deadline for any response or corrective action.
Reconcile the records
Compare physical stock with the relevant drug register, prescriptions, dispensing records and supply documentation to determine where the difference occurred.
Address immediate risks
Where the discrepancy raises medicine-security, diversion or patient-safety concerns, take the required immediate action while preserving the original evidence.
Correct the underlying process
Update the relevant medicinal cannabis dispensary SOPs, staff responsibilities or controls and retain evidence showing that the revised process is working.
Why work with HCPA on medicinal cannabis compliance?
Compliance in pharmacies specialising in medicinal cannabis dispensing combines standard pharmacy obligations with additional considerations around Schedule 8 medicines, unapproved therapeutic goods and prescription medicine advertising.
HCPA can review how these requirements interact across dispensing, controlled-drug records, public communications and prescriber relationships rather than treating each issue separately.
businesses supported
industry consultants
billion in client revenue
This can help identify where operational controls need to be strengthened before an inspection, complaint or regulatory review exposes the gap.
Frequently asked questions about medicinal cannabis compliance
How should a medicinal cannabis dispensary manage storage, dispensing records and controlled-drug requirements?
Start by mapping the requirements applying to the medicines being dispensed and the pharmacy’s jurisdiction.
For Schedule 8 medicinal cannabis, this can include secure storage, authorised access, drug-register records, stock reconciliation and applicable real-time prescription monitoring.
The pharmacy’s medicinal cannabis policies and procedures should then connect those requirements to the actual ordering, dispensing and record-keeping workflow.
What should a pharmacy do when an audit identifies discrepancies in its medicinal cannabis stock or records?
Treat the discrepancy seriously and establish the facts before altering any records.
Reconcile physical stock against drug-register entries, prescriptions and dispensing records, then determine whether the issue involves a recording error, stock-handling problem or wider control failure.
Corrective action should address both the immediate discrepancy and the process that allowed it to occur, with any jurisdiction-specific reporting requirements also checked.
What should medicinal cannabis dispensary SOPs include?
Medicinal cannabis dispensary SOPs should translate regulatory requirements into clear processes for ordering, storage, prescription checks, dispensing, stock reconciliation, monitoring and incident escalation.
They should also identify staff responsibilities, required records and when an issue needs to be escalated so compliance does not depend on individual knowledge.
Do medicinal cannabis dispensing regulations differ between states and territories?
Yes. Commonwealth requirements apply to areas such as access to unapproved therapeutic goods and therapeutic-goods advertising, while medicines and poisons laws are also administered by states and territories.
This means Schedule 8 storage, prescribing, dispensing and monitoring requirements should be checked for the jurisdiction in which the pharmacy operates.
Australia’s National Real Time Prescription Monitoring framework supports jurisdictional systems, but the exact obligations still depend on the relevant state or territory.
Could a cannabis leaf or the words “plant medicine” cause an advertising issue?
Potentially.
The TGA assesses advertising in context, so indirect wording or cannabis imagery can still promote medicinal cannabis even where a medicine is not named.
The pharmacy should review branding, website content and social media as a whole against the TGA’s prescription medicine advertising restrictions.
What should I do if the TGA contacts the pharmacy about its website?
Identify exactly which content is being questioned and preserve a copy of what was published.
Problematic content may need to be removed or suspended, but the review should extend beyond one page. Similar issues may exist across social media, landing pages, signage or other marketing assets.
The pharmacy should also review the approval process for future public-facing content so the same issue is less likely to recur.
Can a pharmacy have a commercial relationship with a medicinal cannabis prescriber?
A commercial relationship does not remove either professional’s independent obligations.
The structure should preserve prescribing and dispensing independence, avoid inappropriate incentives and allow patients genuine choice.
A documented conflict-of-interest process can help show how those responsibilities are protected in practice.
What happens if a pharmacy fails a Schedule 8 inspection?
The outcome depends on the issue and regulator.
A storage issue may require physical remediation, while a record discrepancy can require a wider review of stock handling, access and dispensing processes.
A strong response should address both the finding and the medicinal cannabis dispensary SOPs or controls that allowed the issue to occur.
What should a pharmacy check before increasing its medicinal cannabis dispensing volume?
Check whether existing Schedule 8 storage capacity, stock controls, staffing and record-keeping systems can handle the additional volume without weakening oversight.
The pharmacy should also review ordering, dispensing, reconciliation and real-time monitoring workflows before volumes increase, rather than waiting for discrepancies or bottlenecks to appear.
